A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males	Anal Cancer, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Genital Diseases, Infections, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, anogenital human papillomavirus infection, anus disorder, anus neoplasm, colorectal neoplasm, common wart, digestive system disorder, digestive system neoplasm, human papilloma virus infection, infectious disease, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile cancer, penile disorder, penile neoplasm, rectal disorder, rectal neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 3	2024-12-12		NCT06465914

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Bovax Biotechnology Co., Ltd.	4

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention	Nanning	China	1
Hunan Center for Disease Control and Prevention	Changsha	China	2
Shanxi Provincial Disease for Control and Prevention	Taiyuan	China	1
Sichuan Center for Disease Control and Prevention	Chengdu	China	3
Yunnan Center for Disease Control and Prevention	Kunming	China	1